Baseline comorbidity in kidney transplant recipients: A comparison of comorbidity indices

被引:132
作者
Jassal, SV
Schaubel, DE
Fenton, SSA
机构
[1] Univ Toronto, Hlth Network, Div Nephrol, Toronto, ON M5G 2C4, Canada
[2] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada
[3] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA
关键词
renal transplant; comorbidity; outcome; patient survival; Charlson Comorbidity Index (CCI); prognosis;
D O I
10.1053/j.ajkd.2005.03.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: An increasing number of patients starting renal replacement therapy are older and have complex comorbidity. In keeping with these demographics, an increased number of older patients undergo transplantation each year. To date, no study has reported baseline comorbidity characteristics of those who underwent transplantation, validated the use of comorbidity indices, or asked whether comorbidity predicts patient outcome after kidney transplantation. Our objective is to report baseline comorbidity and compare the use of different indices for recipients of kidneys from both deceased and living donors. Methods: Using data from the Canadian Organ Replacement Registry, we tested the ability of 4 comorbidity indices to predict patient survival by using a Cox regression model. Model covariates included donor source, age, race, sex, treatment period, primary renal disease cause, months on dialysis therapy, and comorbidities. Results: A total of 6,324 patients were included; 22% had >= 1 comorbid condition at baseline. After adjustment for age, sex, and cause of renal disease, increased comorbidity was associated strongly with reduced patient survival. Of all comorbidity indices examined, the model containing the Charlson Comorbidity Index (CCI) offered the best fit. The model containing log-CCI had an index of concordance of 74%. Conclusion: The CCI is a suitable tool for the measurement of comorbidity in renal transplant recipients. (c) 2005 by the National Kidney Foundation, Inc.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 20 条
[1]   Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease [J].
Athienites, NV ;
Miskulin, DC ;
Fernandez, G ;
Bunnapradist, S ;
Simon, G ;
Landa, M ;
Schmid, CH ;
Greenfield, S ;
Levey, AS ;
Meyer, KB .
SEMINARS IN DIALYSIS, 2000, 13 (05) :320-326
[2]   A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients [J].
Beddhu, S ;
Bruns, FJ ;
Saul, M ;
Seddon, P ;
Zeidel, ML .
AMERICAN JOURNAL OF MEDICINE, 2000, 108 (08) :609-613
[3]   Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries [J].
Berthoux, F ;
Jones, E ;
Gellert, R ;
Mendel, S ;
Saker, L ;
Briggs, D .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (10) :2332-2342
[4]  
*CAN I HLTH INF, 2002, 2002 CORR PREL REP P
[5]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]  
Davies SJ, 2003, CONTRIB NEPHROL, V140, P98
[7]   Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival [J].
Davies, SJ ;
Phillips, L ;
Naish, PF ;
Russell, GI .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (06) :1085-1092
[8]   Co-morbidity and kidney graft failure - two main causes of malnutrition in kidney transplant patients [J].
Djukanovic, L ;
Lezaic, V ;
Blagojevic, R ;
Radivojevic, D ;
Stosovic, M ;
Jovanovic, N ;
Ristic, S ;
Simic-Ogrizovic, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 :68-70
[9]   Comorbidities in patients with end-stage renal disease in developing countries [J].
Eiam-Ong, S ;
Sitprija, V .
ARTIFICIAL ORGANS, 2002, 26 (09) :753-756
[10]  
Fried L, 2003, PERITON DIALYSIS INT, V23, P568